Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial.

Details

Language :

English

ISSN :

21645515

Volume :

14

Issue :

6

Database :

Complementary Index

Journal :

Human Vaccines & Immunotherapeutics

Publication Type :

Academic Journal

Accession number :

130416902

Full Text :

https://doi.org/10.1080/21645515.2018.1441654